NIGHTSTAR THERAPEUTICS PLC Net Income
NIGHTSTAR THERAPEUTICS PLC reported Net Income of -$16.39 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2019-05-10
- NIGHTSTAR THERAPEUTICS PLC net income (loss) attributable to parent for the quarter ending 2019-03-31 was -$16.39M.
- NIGHTSTAR THERAPEUTICS PLC net income (loss) attributable to parent for the quarter ending 2018-12-31 was -$8.39M.
- NIGHTSTAR THERAPEUTICS PLC net income (loss) attributable to parent for the quarter ending 2018-09-30 was -$6.02M.
- NIGHTSTAR THERAPEUTICS PLC net income (loss) attributable to parent for the quarter ending 2018-06-30 was -$8.10M.
- NIGHTSTAR THERAPEUTICS PLC net income (loss) attributable to parent for fiscal 2018 was -$36.86M.
- NIGHTSTAR THERAPEUTICS PLC net income (loss) attributable to parent for fiscal 2017 was -$29.69M.
- NIGHTSTAR THERAPEUTICS PLC net income (loss) attributable to parent for fiscal 2016 was -$12.20M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2019-03-31 | -$16.39M 10-Q · filed 2019-05-10 | -$24.78M derived: sum of 2 quarters · filed 2019-05-10 | -$30.80M derived: sum of 3 quarters · filed 2019-05-10 | -$38.90M derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-12-31 | -$8.39M 10-K · filed 2019-03-18 | -$14.41M derived: sum of 2 quarters · filed 2019-03-18 | -$22.50M derived: sum of 3 quarters · filed 2019-03-18 | -$36.86M 10-K · filed 2019-03-18 |
| 2018-09-30 | -$6.02M 10-K · filed 2019-03-18 | -$14.12M derived: sum of 2 quarters · filed 2019-03-18 | -$28.48M 6-K · filed 2018-11-20 | -$42.26M derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-06-30 | -$8.10M 10-K · filed 2019-03-18 | -$22.45M 6-K · filed 2018-08-15 | -$36.24M derived: sum of 3 quarters · filed 2019-05-10 | -$44.45M derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-03-31 | -$14.36M 10-Q · filed 2019-05-10 | -$28.14M derived: sum of 2 quarters · filed 2019-05-10 | -$36.35M derived: sum of 3 quarters · filed 2019-05-10 | -$40.57M derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | -$13.78M 10-K · filed 2019-03-18 | -$21.99M derived: sum of 2 quarters · filed 2019-03-18 | -$26.21M derived: sum of 3 quarters · filed 2019-03-18 | -$29.69M 10-K · filed 2019-03-18 |
| 2017-09-30 | -$8.21M 10-K · filed 2019-03-18 | -$12.43M derived: sum of 2 quarters · filed 2019-03-18 | -$15.90M 6-K · filed 2018-11-20 | |
| 2017-06-30 | -$4.22M 10-K · filed 2019-03-18 | -$7.69M 6-K · filed 2018-08-15 | ||
| 2017-03-31 | -$3.47M 10-K · filed 2019-03-18 | |||
| 2016-12-31 | -$12.20M 10-K · filed 2019-03-18 | |||
| 2015-12-31 | -$13.65M 20-F · filed 2018-04-03 |